GILD in the 13F filings
Gilead Sciences Inc · CUSIP 375558103
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 13 Nov 2025
- Managers listing it
- 23
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 23 listed it in both
- Shares listed
- 264,727,452
- combined, among listed positions
- Reported value
- $29.4bn
- combined, at the quarter end
Among the 95 comparable managers: 9 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing GILD in Q3 2025
23 of 23 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 26,503,391 shares now+2,916,699
- Invesco Ltdexisting position · 15,139,681 shares now+1,618,453
- Janus Henderson Group Ltdexisting position · 1,658,462 shares now+526,945
- Squarepoint Ops LLCexisting position · 799,736 shares now+459,202
- Fidelity (FMR LLC)existing position · 60,316,279 shares now+360,902
Reductions
- Wellington Management Group LLPexisting position · 25,618,534 shares now-11,911,976
- Holocene Advisors LPexisting position · 2,617,172 shares now-1,609,799
- Capital World Investorsexisting position · 45,179,931 shares now-1,123,368
- Capital Research Global Investorsexisting position · 30,014,046 shares now-1,083,633
- Dodge & Coxexisting position · 30,133,131 shares now-685,191
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 22 | $26.4bn | n.a. | n.a. |
| Q3 2013 | 20 | $31.7bn | n.a. | n.a. |
| Q4 2013 | 24 | $35.6bn | n.a. | n.a. |
| Q1 2014 | 26 | $30.7bn | n.a. | n.a. |
| Q2 2014 | 26 | $35.5bn | n.a. | n.a. |
| Q3 2014 | 28 | $40.8bn | n.a. | n.a. |
| Q4 2014 | 30 | $30.9bn | n.a. | n.a. |
| Q1 2015 | 32 | $31.9bn | n.a. | n.a. |
| Q2 2015 | 31 | $36.4bn | n.a. | n.a. |
| Q3 2015 | 31 | $27.6bn | n.a. | n.a. |
| Q4 2015 | 34 | $25.0bn | n.a. | n.a. |
| Q1 2016 | 35 | $18.5bn | n.a. | n.a. |
| Q2 2016 | 33 | $15.5bn | n.a. | n.a. |
| Q3 2016 | 30 | $12.9bn | n.a. | n.a. |
| Q4 2016 | 33 | $11.4bn | n.a. | n.a. |
| Q1 2017 | 33 | $9.9bn | n.a. | n.a. |
| Q2 2017 | 33 | $10.4bn | n.a. | n.a. |
| Q3 2017 | 27 | $12.4bn | n.a. | n.a. |
| Q4 2017 | 28 | $12.3bn | n.a. | n.a. |
| Q1 2018 | 32 | $14.0bn | n.a. | n.a. |
| Q2 2018 | 29 | $13.6bn | n.a. | n.a. |
| Q3 2018 | 29 | $15.6bn | n.a. | n.a. |
| Q4 2018 | 32 | $13.3bn | n.a. | n.a. |
| Q1 2019 | 32 | $14.9bn | n.a. | n.a. |
| Q2 2019 | 29 | $16.1bn | n.a. | n.a. |
| Q3 2019 | 30 | $13.9bn | n.a. | n.a. |
| Q4 2019 | 32 | $14.3bn | n.a. | n.a. |
| Q1 2020 | 28 | $17.0bn | n.a. | n.a. |
| Q2 2020 | 23 | $18.7bn | n.a. | n.a. |
| Q3 2020 | 25 | $14.2bn | n.a. | n.a. |
| Q4 2020 | 27 | $13.4bn | n.a. | n.a. |
| Q1 2021 | 24 | $14.5bn | n.a. | n.a. |
| Q2 2021 | 18 | $14.9bn | n.a. | n.a. |
| Q3 2021 | 20 | $16.4bn | n.a. | n.a. |
| Q4 2021 | 20 | $16.8bn | n.a. | n.a. |
| Q1 2022 | 28 | $13.2bn | n.a. | n.a. |
| Q2 2022 | 26 | $13.6bn | n.a. | n.a. |
| Q3 2022 | 24 | $13.3bn | n.a. | n.a. |
| Q4 2022 | 32 | $21.1bn | n.a. | n.a. |
| Q1 2023 | 27 | $21.8bn | n.a. | n.a. |
| Q2 2023 | 24 | $20.7bn | n.a. | n.a. |
| Q3 2023 | 24 | $20.0bn | n.a. | n.a. |
| Q4 2023 | 22 | $21.5bn | 10 | 11 |
| Q1 2024 | 30 | $20.3bn | 17 | 12 |
| Q2 2024 | 28 | $18.5bn | 15 | 14 |
| Q3 2024 | 29 | $24.2bn | 15 | 15 |
| Q4 2024 | 28 | $25.9bn | 14 | 14 |
| Q1 2025 | 33 | $32.0bn | 21 | 12 |
| Q2 2025 | 27 | $30.9bn | 18 | 10 |
| Q3 2025 | 23 | $29.4bn | 9 | 14 |
| Q4 2025 | 25 | $34.3bn | 18 | 19 |
| Q1 2026 | 25 | $38.5bn | 16 | 21 |
| Q2 2026 | 26 | $34.2bn | 22 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GILD and AMGN →GILD and ARGX →GILD and RVMD →Choose a stock to compare with GILD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GILD, latest filings →Back to the 13F Explorer →